<DOC>
	<DOCNO>NCT01009749</DOCNO>
	<brief_summary>This two-phase study , consist follow plan : Phase I - This pre-test feasibility acceptability beta version computer-delivered intervention , Motivational Enhancement System Adherence ( MESA ) , well control intervention Motivational Enhancement System Health ( MESH ) three select AMTUs . Following analysis response Phase I modification intervention , Phase II initiate . Phase II - This pilot , randomize , control trial ( RCT ) test two-session computer-delivered intervention , MESA , design increase motivation adherence Highly Active Antiretroviral Therapy ( HAART ) among youth newly recommend begin medication , well attention control , MESH , match dose delivery format . Phase II open 15 AMTUs .</brief_summary>
	<brief_title>Motivational Enhancement System Adherence</brief_title>
	<detailed_description />
	<criteria>Phase I &amp; II , participant Engaged care enrol AMTU ; HIV1 infection document positive result follow licensed test time : HIV1 antibody test confirm Western blot , HIV1 culture , HIV1 DNA PCR , plasma HIV1 RNA PCR &gt; 1,000 copies/ml ; Age 16 24 year , inclusive time enrollment ; Naïve antiretroviral therapy ; NOTE : Females receive antiretroviral therapy sole purpose prevent maternal child transmission ( MTCT ) consider antiretroviral naïve . Ability understand write and/or spoken English ; Willingness provide sign informed consent/assent either English Spanish ; Parental legal guardian permission , warrant . Phase I MESA Participants/Phase II All Participants Recommended health care provider start HAART treatment HIV1 infection within 12 week prior protocol screen . Phase I MESH Participants Not recommend health care provider start HAART treatment HIV1 infection . Phase I &amp; II , participant Known pregnancy ( pregnancy test require ) ; Inability understand speak write English ; Visibly distraught and/or visibly emotionally unstable ( e.g. , exhibit suicidal , homicidal , manic violent behavior ) ; Active drug alcohol use dependence , opinion site personnel , would interfere ability give true informed consent adhere study requirement ; Active psychiatric condition opinion site personnel , would interfere ability give true informed consent adhere study requirement ; Acute illness , opinion treat clinician , would interfere participant 's ability adhere protocol requirement and/or interfere protocol objective ; Concurrent participation participation within previous 4 week , behavioral intervention study program , include , limited , ATN 069 ATN 073 . Permission coenroll behavioral study program must obtain protocol chair designee . Phase II , All Participants Prior participation Phase I MESA intervention ( Phase I MESH control participant eligible participate ) .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>HAART</keyword>
	<keyword>HIV</keyword>
	<keyword>Adherence</keyword>
</DOC>